[1]. Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using the novel surgical robot platform, hinotori: Initial experience with two cases.
IJU case reports [巻]7 [号]2 [頁]96 -99 （2024年） [査読] 有
[DOI] [2]. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.
Anticancer research [巻]44 [号]2 [頁]781 -786 （2024年） [査読] 有
[DOI] [3]. Robot-assisted radical nephroureterectomy for upper urinary tract tumor: initial experience with the use of novel surgical robot system, hinotori.
Translational cancer research [巻]12 [号]12 [頁]3522 -3529 （2023年） [査読] 有
[DOI] [4]. Robot-assisted radical nephrectomy using novel surgical robot platform, hinotori: Report of initial series of 13 cases.
International journal of urology : official journal of the Japanese Urological Association [巻]30 [号]12 [頁]1175 -1179 （2023年） [査読] 有
[DOI] [5]. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Urologic oncology [巻]41 [号]11 [頁]458.e9 -458.e19 （2023年） [査読] 有
[DOI]